兆豐股份(300695.SZ)擬7200萬元組建陝西陝汽兆豐科技有限公司 持股60%
格隆匯9月8日丨兆豐股份(300695.SZ)公佈,為最大限度發揮合作各方資源優勢,公司與陝汽集團、陝西東銘、陝西華航於2020年9月8日於陝西省西安市簽訂《合作框架協議》,在汽車零部件業務方面開展全方位深度合作。公司與陝西東銘、陝西華航擬組建合資公司“陝西陝汽兆豐科技有限公司”(暫定名,具體以工商部門核准為準),該合資公司一期註冊資本擬為1.2億元人民幣,其中公司出資額擬為7200萬元人民幣,佔註冊資本的60%。
合資公司將從事商用車汽車輪轂軸承單元及其他底盤系統相關業務的研發、生產和銷售,陝汽集團承諾合作期間,給予合資公司一定比例的採購份額的保證。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.